PMS2 and neoplasm: Although the tumor profile of the Leu676Pro carrier did not showed MSI and IHC revealed normal nuclear staining of the four protein, we decided to further evaluate the impact of this novel variant on subcellular localization and MLH1-PMS2 dimerization, as suggested elsewhere [26].